Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 4 other studies
7,769people with hypertension, in this paper
The trial randomly assignedassigned by chance
pitavastatin
placebo
Lowered hypertension−17%
randomisedthe abstract, start to end
… (cause-specific hazard ratio [HR] 0.83, 95% CI 0.71-0.97; p=0.017).
← favours treatmentfavours comparator →
could be chanceIncidence of hypertensionpitavastatin vs placebo
HR 0.830.71–0.97
StatinsBlood pressure
Statins × blood pressurehelps?replicated
unlikelylikely
0.830.80 without it
← favours comparatorfavours treatment →
1 / 6